Melrose FutureLab

NMN Capsules 250mg

Foundational CellVive NMN® support to maintain cellular energy production and nervous system health.

Energy Production
Nervous System
Daily Wellbeing
Best Value
Auto-deliver & Save 13% 30 Hard Capsules / 30 Day Supply
$58.95 $51.28
$1.70 Per day
  • Delivery Every 30 Days
  • Delivery Every 60 Days
  • Delivery Every 90 Days
13% Off Every Order
Pause or Cancel Anytime
One Time Purchase 30 Hard Capsules / 30 Day Supply
$58.95

Always read the label and follow the directions for use. Read the warnings below.

Frequently Purchased:

Time Capsule™ Daily Longevity Complex
Time Capsule™ Daily Longevity Complex
$99.99

All-In-One Longevity Formula^ with Berberine

See warnings here

Berberine Complex
Berberine Complex
$48.55

Bioavailable Metabolism Support

See warnings here

FutureLab NMN 250mg capsules provide nicotinamide mononucleotide (NMN) in a foundational daily capsule. As we age, the way our cells function naturally changes and that can affect energy levels, resilience and everyday wellbeing.

This balanced capsule is formulated to support energy production and body metabolism, help maintain physical endurance, capacity and stamina in aging individuals, and support nervous system health and function. It's designed to support general health and wellbeing, including in aging individuals, a good starting point for anyone beginning an NMN routine or looking for consistent, foundational support.

4 Benefits of NMN

Key ingredients

Daily Foundational Support for Energy and Wellbeing

Daily Foundational Support for Energy and Wellbeing

FutureLab NMN 250 mg offers daily support in capsule form for those looking to introduce NMN into their health routine with a simple, consistent dose.

✓ Vegan
✓ Dairy Free
✓ Gluten Free
✓ Proudly Australian Owned

Still have questions?

See what most people ask before trying. See all FAQs or Contact Us and our team will be happy to help.

References

CellVive NMN® logo and CellVive NMN® is a registered trademark of Longevity Life Sciences Pty Ltd.

Bogan, K. L., & Brenner, C. (2008).
Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD⁺ precursor vitamins in human nutrition.
Annual Review of Nutrition, 28, 115–130.
https://doi.org/10.1146/annurev.nutr.28.061807.155443

Yoshino, J., Baur, J. A., & Imai, S. I. (2018).
NAD⁺ intermediates: The biology and therapeutic potential of NMN and NR.
Cell Metabolism, 27(3), 513–528.
https://doi.org/10.1016/j.cmet.2017.11.002

Imai, S. I., & Guarente, L. (2014).
NAD⁺ and sirtuins in aging and disease.
Trends in Cell Biology, 24(8), 464–471.
https://doi.org/10.1016/j.tcb.2014.04.002

Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., et al. (2016).
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.
Nature Communications, 7, 12948.
https://doi.org/10.1038/ncomms12948

Australian Government Department of Health and Aged Care.
Australian Register of Therapeutic Goods (ARTG): Listed medicines containing Nicotinamide Mononucleotide.
https://www.tga.gov.au

NMN 250 mg – Daily NMN for Energy Production & Wellbeing Support | Melrose FutureLab